Validation of a Virtual Assistant for Improving Medication Adherence in Patients with Comorbid Type 2 Diabetes Mellitus and Depressive Disorder

Virtual assistants are programs that interact with users through text or voice messages simulating a human-based conversation. The development of healthcare virtual assistants that use messaging platforms is rapidly increasing. Still, there is a lack of validation of these assistants. In particular,...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Surya Roca, María Luisa Lozano, José García, Álvaro Alesanco
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	chat-based interaction eHealth mHealth chronic disease diabetes depressive disorder Medicine R
Acceso en línea:	https://doaj.org/article/6c2bd0b44b3f47619be0e449e6e759c0
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:6c2bd0b44b3f47619be0e449e6e759c0
record_format	dspace
spelling	oai:doaj.org-article:6c2bd0b44b3f47619be0e449e6e759c02021-11-25T17:50:41ZValidation of a Virtual Assistant for Improving Medication Adherence in Patients with Comorbid Type 2 Diabetes Mellitus and Depressive Disorder10.3390/ijerph1822120561660-46011661-7827https://doaj.org/article/6c2bd0b44b3f47619be0e449e6e759c02021-11-01T00:00:00Zhttps://www.mdpi.com/1660-4601/18/22/12056https://doaj.org/toc/1661-7827https://doaj.org/toc/1660-4601Virtual assistants are programs that interact with users through text or voice messages simulating a human-based conversation. The development of healthcare virtual assistants that use messaging platforms is rapidly increasing. Still, there is a lack of validation of these assistants. In particular, this work aimed to validate the effectiveness of a healthcare virtual assistant, integrated within messaging platforms, with the aim of improving medication adherence in patients with comorbid type 2 diabetes mellitus and depressive disorder. For this purpose, a nine-month pilot study was designed and subsequently conducted. The virtual assistant reminds patients about their medication and provides healthcare professionals with the ability to monitor their patients. We analyzed the medication possession ratio (MPR), measured the level of glycosylated hemoglobin (HbA1c), and obtained the patient health questionnaire (PHQ-9) score in the patients before and after the study. We also conducted interviews with all participants. A total of thirteen patients and five nurses used and evaluated the proposed virtual assistant using the messaging platform Signal. Results showed that on average, the medication adherence improved. In the final interview, 69% of the patients agreed with the idea of continuing to use the virtual assistant after the study.Surya RocaMaría Luisa LozanoJosé GarcíaÁlvaro AlesancoMDPI AGarticlechat-based interactioneHealthmHealthchronic diseasediabetesdepressive disorderMedicineRENInternational Journal of Environmental Research and Public Health, Vol 18, Iss 12056, p 12056 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	chat-based interaction eHealth mHealth chronic disease diabetes depressive disorder Medicine R
spellingShingle	chat-based interaction eHealth mHealth chronic disease diabetes depressive disorder Medicine R Surya Roca María Luisa Lozano José García Álvaro Alesanco Validation of a Virtual Assistant for Improving Medication Adherence in Patients with Comorbid Type 2 Diabetes Mellitus and Depressive Disorder
description	Virtual assistants are programs that interact with users through text or voice messages simulating a human-based conversation. The development of healthcare virtual assistants that use messaging platforms is rapidly increasing. Still, there is a lack of validation of these assistants. In particular, this work aimed to validate the effectiveness of a healthcare virtual assistant, integrated within messaging platforms, with the aim of improving medication adherence in patients with comorbid type 2 diabetes mellitus and depressive disorder. For this purpose, a nine-month pilot study was designed and subsequently conducted. The virtual assistant reminds patients about their medication and provides healthcare professionals with the ability to monitor their patients. We analyzed the medication possession ratio (MPR), measured the level of glycosylated hemoglobin (HbA1c), and obtained the patient health questionnaire (PHQ-9) score in the patients before and after the study. We also conducted interviews with all participants. A total of thirteen patients and five nurses used and evaluated the proposed virtual assistant using the messaging platform Signal. Results showed that on average, the medication adherence improved. In the final interview, 69% of the patients agreed with the idea of continuing to use the virtual assistant after the study.
format	article
author	Surya Roca María Luisa Lozano José García Álvaro Alesanco
author_facet	Surya Roca María Luisa Lozano José García Álvaro Alesanco
author_sort	Surya Roca
title	Validation of a Virtual Assistant for Improving Medication Adherence in Patients with Comorbid Type 2 Diabetes Mellitus and Depressive Disorder
title_short	Validation of a Virtual Assistant for Improving Medication Adherence in Patients with Comorbid Type 2 Diabetes Mellitus and Depressive Disorder
title_full	Validation of a Virtual Assistant for Improving Medication Adherence in Patients with Comorbid Type 2 Diabetes Mellitus and Depressive Disorder
title_fullStr	Validation of a Virtual Assistant for Improving Medication Adherence in Patients with Comorbid Type 2 Diabetes Mellitus and Depressive Disorder
title_full_unstemmed	Validation of a Virtual Assistant for Improving Medication Adherence in Patients with Comorbid Type 2 Diabetes Mellitus and Depressive Disorder
title_sort	validation of a virtual assistant for improving medication adherence in patients with comorbid type 2 diabetes mellitus and depressive disorder
publisher	MDPI AG
publishDate	2021
url	https://doaj.org/article/6c2bd0b44b3f47619be0e449e6e759c0
work_keys_str_mv	AT suryaroca validationofavirtualassistantforimprovingmedicationadherenceinpatientswithcomorbidtype2diabetesmellitusanddepressivedisorder AT marialuisalozano validationofavirtualassistantforimprovingmedicationadherenceinpatientswithcomorbidtype2diabetesmellitusanddepressivedisorder AT josegarcia validationofavirtualassistantforimprovingmedicationadherenceinpatientswithcomorbidtype2diabetesmellitusanddepressivedisorder AT alvaroalesanco validationofavirtualassistantforimprovingmedicationadherenceinpatientswithcomorbidtype2diabetesmellitusanddepressivedisorder
_version_	1718411925364146176

Validation of a Virtual Assistant for Improving Medication Adherence in Patients with Comorbid Type 2 Diabetes Mellitus and Depressive Disorder

Ejemplares similares